Article
AHNAK2: a potential diagnostic biomarker for pancreatic cancer related to cellular motility
23 Jan 2025
Abstract excerpt
Pancreatic ductal adenocarcinoma lacks suitable biomarkers for early diagnosis of disease. In gene panels developed for early diagnosis of pancreatic cancer, high AHNAK2 mRNA expression was one possible biomarker. In silico analysis of published human sample datasets (n = 177) and ex vivo analysis of human plasma samples (n = 30 PDAC with matched 30 healthy control) suggested AHNAK2 could be a diagnostic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
